Neuronetics announced the U.S. Food and Drug Administration 510(k) clearance of NeuroSite Coil Placement Accessory, a tool that simplifies measurement and coil positioning during NeuroStar transcranial magnetic stimulation treatments. This proprietary accessory, designed with versatility and provider convenience in mind, seamlessly integrates with both legacy and new NeuroStar systems and further enhances efficiency and patient experience.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on STIM:
- NeuroStar TMS Receives Expanded Regulatory Approval in Japan
- Neuronetics’s NeuroStar TMS receives expanded regulatory approval in Japan
- Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
- Neuronetics upgrades software solutions for depression treatment
- NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
